SCHEMBL6759593

SCHEMBL6759593

O=c1oc(Oc2ccc([N+](=O)[O-])cc2)cn1Cc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 3/20 0.46
ABHD6 Q9BV23 1/20 0.46
CYP19A1 P11511 1/20 0.46
HTT P42858 1/20 0.44
KMT2A Q03164 3/20 0.42
MEN1 O00255 2/20 0.42
NR3C1 P04150 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
FAAH O00519 2/20 0.41
ACHE P22303 1/20 0.40
POLB P06746 1/20 0.40
P2RX4 Q99571 1/20 0.40
DRD2 P14416 1/20 0.40
DRD4 P21917 1/20 0.40
DRD3 P35462 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764108 0.86 MEN1 (0.48) MGLLABHD6HTTKMT2AMEN1
SCHEMBL7672076 0.78 CA12 (0.43) HTTKMT2AMEN1CA12CA9
SCHEMBL4680991 0.73 HPGD (0.49) MGLLHTTKMT2AMEN1ALDH1A1
SCHEMBL6757710 0.72 MAPK14 (0.49) MGLLHTTKMT2AMEN1ALDH1A1
SCHEMBL6759650 0.71 HPGD (0.47) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL6764255 0.70 TP53 (0.45) MGLLHTTKMT2AMEN1ALDH1A1
SCHEMBL9453625 0.70 KMT2A (0.54) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL5925051 0.70 KMT2A (0.48) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL6757705 0.70 HPGD (0.46) HTTKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL6761320 0.69 HPGD (0.44) HTTKMT2AMEN1ALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723860-B2 7a-alkoxy-4H-pyrano[3,2-d]-oxazol-2(3H)-one and process for producing the same UBE INDUSTRIES, LTD. (JP) 2004-04-20 US disclosed
EP-1207162-B1 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same UBE INDUSTRIES (JP) 2004-02-25 EP disclosed
US-20020072612-A1 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same UBE INDUSTRIES, LTD. (JP) 2002-06-13 US disclosed
EP-1207162-A1 7a-alkoxy-4H-pyrano-[3,2-d]-oxazol-2(3H)-one and process for producing the same Ube Industries, Ltd. (JP) 2002-05-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020072612-A1 7a-alkoxy-4H-pyrano [3,2-d] -oxazol-2 (3H) -one and process for producing the same ACSL1, ACSL4, ACSL3 MGLL 87/4885ABHD6 1148/4885CYP19A1 872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.